BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 22208970)

  • 1. Silencing fibronectin extra domain A enhances radiosensitivity in nasopharyngeal carcinomas involving an FAK/Akt/JNK pathway.
    Ou J; Pan F; Geng P; Wei X; Xie G; Deng J; Pang X; Liang H
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e685-91. PubMed ID: 22208970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. αV integrin induces multicellular radioresistance in human nasopharyngeal carcinoma via activating SAPK/JNK pathway.
    Ou J; Luan W; Deng J; Sa R; Liang H
    PLoS One; 2012; 7(6):e38737. PubMed ID: 22719931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo and In Vitro Effects of ATM/ATR Signaling Pathway on Proliferation, Apoptosis, and Radiosensitivity of Nasopharyngeal Carcinoma Cells.
    Wang M; Liu G; Shan GP; Wang BB
    Cancer Biother Radiopharm; 2017 Aug; 32(6):193-203. PubMed ID: 28820634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor and radiosensitizing effects of SKLB-163, a novel benzothiazole-2-thiol derivative, on nasopharyngeal carcinoma by affecting the RhoGDI/JNK-1 signaling pathway.
    He J; Cai L; Chen Y; He Y; Wang M; Tang J; Guan H; Wang J; Peng X
    Radiother Oncol; 2018 Oct; 129(1):30-37. PubMed ID: 29519627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced RKIP enhances nasopharyngeal carcinoma radioresistance by increasing ERK and AKT activity.
    Yuan L; Yi HM; Yi H; Qu JQ; Zhu JF; Li LN; Xiao T; Zheng Z; Lu SS; Xiao ZQ
    Oncotarget; 2016 Mar; 7(10):11463-77. PubMed ID: 26862850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of β-Catenin Decreases the Radiosensitivity of Human Nasopharyngeal Carcinoma CNE-2 Cells.
    He H; Lin K; Su Y; Lin S; Zou C; Pan J; Zhou Y; Chen C
    Cell Physiol Biochem; 2018; 50(5):1929-1944. PubMed ID: 30396174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of ZIP4 reverses epithelial-to-mesenchymal transition and enhances the radiosensitivity in human nasopharyngeal carcinoma cells.
    Zeng Q; Liu YM; Liu J; Han J; Guo JX; Lu S; Huang XM; Yi P; Lang JY; Zhang P; Wang CT
    Cell Death Dis; 2019 Aug; 10(8):588. PubMed ID: 31383854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHAF1B induces radioresistance by promoting DNA damage repair in nasopharyngeal carcinoma.
    Di M; Wang M; Miao J; Chen B; Huang H; Lin C; Jian Y; Li Y; Ouyang Y; Chen X; Wang L; Zhao C
    Biomed Pharmacother; 2020 Mar; 123():109748. PubMed ID: 31869663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastasis-suppressing NID2, an epigenetically-silenced gene, in the pathogenesis of nasopharyngeal carcinoma and esophageal squamous cell carcinoma.
    Chai AW; Cheung AK; Dai W; Ko JM; Ip JC; Chan KW; Kwong DL; Ng WT; Lee AW; Ngan RK; Yau CC; Tung SY; Lee VH; Lam AK; Pillai S; Law S; Lung ML
    Oncotarget; 2016 Nov; 7(48):78859-78871. PubMed ID: 27793011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FBP1 enhances the radiosensitivity by suppressing glycolysis via the FBXW7/mTOR axis in nasopharyngeal carcinoma cells.
    Zhang P; Shao Y; Quan F; Liu L; Yang J
    Life Sci; 2021 Oct; 283():119840. PubMed ID: 34298040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
    Wang B; Gu Q; Li J
    Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol enhances the radiosensitivity of nasopharyngeal carcinoma cells by downregulating E2F1.
    Tan Y; Wei X; Zhang W; Wang X; Wang K; Du B; Xiao J
    Oncol Rep; 2017 Mar; 37(3):1833-1841. PubMed ID: 28184930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Notch2 enhances radiosensitivity via inhibition of the AKT/mTOR signaling pathway in nasopharyngeal carcinoma.
    Wu LZ; Huang ML; Qi CL; Shen LJ; Zou Y; Yang R; Sheng JF; Chen SM
    Bioengineered; 2021 Dec; 12(1):3398-3409. PubMed ID: 34224316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of GnT-V enhances nasopharyngeal carcinoma cell CNE-2 radiosensitivity in vitro and in vivo.
    Zhuo E; He J; Wei T; Zhu W; Meng H; Li Y; Guo L; Zhang J
    Biochem Biophys Res Commun; 2012 Aug; 424(3):554-62. PubMed ID: 22780953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of recombinant lentiviral vector encoding miR-15a/16-1 in biological features of human nasopharyngeal carcinoma CNE-2Z cells.
    Zhang C; Fang X; Li W; Shi Q; Wu L; Chen X; Huang Z; Wu P; Wang Z; Liao Z
    Cancer Biother Radiopharm; 2014 Dec; 29(10):422-7. PubMed ID: 25405832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The important role of the receptor for activated C kinase 1 (RACK1) in nasopharyngeal carcinoma progression.
    Peng H; Gong PG; Li JB; Cai LM; Yang L; Liu YY; Yao KT; Li X
    J Transl Med; 2016 May; 14(1):131. PubMed ID: 27170279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing vascular endothelial growth factor C increases the radiosensitivity in nasopharyngeal carcinoma CNE-2 cells.
    Wang F; Peng L; Wang Y; Liu X
    J Cell Biochem; 2020 Feb; 121(2):1182-1191. PubMed ID: 31478229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathway.
    Nie X; Guo E; Wu C; Liu D; Sun W; Zhang L; Long G; Mei Q; Wu K; Xiong H; Hu G
    Cancer Med; 2019 Apr; 8(4):1779-1792. PubMed ID: 30907073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting FAK radiosensitizes 3-dimensional grown human HNSCC cells through reduced Akt1 and MEK1/2 signaling.
    Hehlgans S; Eke I; Cordes N
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e669-76. PubMed ID: 22483702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The extra domain A of fibronectin increases VEGF-C expression in colorectal carcinoma involving the PI3K/AKT signaling pathway.
    Xiang L; Xie G; Ou J; Wei X; Pan F; Liang H
    PLoS One; 2012; 7(4):e35378. PubMed ID: 22496919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.